EPRF Innovator S&P Investment Grade Preferred ETF

Innovator Capital Management, LLC (Innovator) announced today the Innovator IBD® Breakout Opportunities ETF (BOUT) has begun trading on the NYSE Arca. BOUT provides investors with exposure to Investor’s Business Daily’s signature breakout methodology of investing with roots dating back to William O’Neil’s research in the 1950’s.

The Innovator IBD Breakout Opportunities ETF (BOUT) seeks to track the performance of the IBD Breakout Stocks Index. The IBD Breakout Stocks Index is a rules-based index developed by Investor’s Business Daily® that is designed to provide investment exposure to stocks poised to “breakout,” or experience a period of sustained price growth beyond the security’s recent “resistance level.” The Index methodology utilizes a ranking score based upon the security’s IBD Composite Ranking and Relative Price Strength Rating to assign weights, and stocks with higher rankings receiving larger weights. The Index includes a minimum of 25 stocks, and is rebalanced and reconstituted on a weekly basis.

“Investor’s Business Daily’s founder William O'Neil began researching breakout stocks in the late 1950s. During more than a half century of research and investing, compiling charts on the best stock market winners of each market cycle, O'Neil found the biggest winners often started their moves the same way, with a stock breakout,” said Chris Gessel, Chief Content Officer of IBD. “The IBD Breakout Stocks Index begins by identifying with companies that have strong fundamental indicators and uses a chart pattern recognition algorithm to select stocks for inclusion that are at or nearing breakout points.”

“While many ETFs focus on stocks with established momentum, the Innovator IBD Breakout Opportunities ETF (BOUT) seeks to identify companies before they have established momentum, and may offer investors unique exposure that can be utilized as an alternative or complement to momentum ETFs,” said Bruce Bond, Chief Executive Officer of Innovator Capital Management. “Identifying stock breakouts from a sound chart pattern is a good way to improve the timing for investing in growth companies, and to participate in potential big stock market winners. We are excited to build on our relationship with Investor’s Business Daily expanding the IBD suite with a third ETF based upon their widely followed investment research.”

About Investor’s Business Daily (IBD)

Investor’s Business Daily is a leading financial news and research organization recognized for providing stock screens, comparative performance ratings, and unique commentary helping investors zero in on top performing growth stocks and ETFs. The company takes a data-first approach to investing, educating investors about how to invest successfully using tested methods and sound research. IBD® offers individual and professional investors a comprehensive lineup of print and online products, all based on a powerful investing system that has dramatically outperformed the S&P 500. IBD® was founded by William J. O'Neil, who also originated CAN SLIM.

About Innovator Capital Management, LLC

Innovator Capital Management, LLC is an SEC registered investment advisor (RIA) based in Wheaton, IL. Formed in 2014, the firm is currently headed by ETF visionaries Bruce Bond and John Southard, founders of one of the largest ETF providers in the world. Innovation is our hallmark and acts as a guide to our company principles. Innovator is committed to helping investors better control their financial outcomes by providing investment opportunities they never considered or thought possible.

Media ContactBill Conboy+1 (303) 415-2290bill@bccapitalpartners.com

Investing involves risks. Principal loss is possible. ETFs face numerous market trading risks, including the potential lack of an active market for Fund shares, losses from trading in secondary markets, periods of high volatility and disruption in the creation/redemption process of the Fund. Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. ETFs are bought and sold at market price and not individually redeemed from the fund. Brokerage commissions will reduce returns. It is not possible to invest directly in an index. The “IBD®” mark and logo have been licensed to the Adviser by Investor’s Business Daily, Inc. (IBD) for use in connection with the Fund under certain circumstances. The Fund is not sponsored, endorsed or sold by IBD. IBD makes no representation regarding the advisability of investing in the Fund. Investor’s Business Daily® mark and associated logos are used with permission by IBD.

The Fund’s investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and may be obtained at innovatoretfs.com. Read it carefully before investing.

Innovator ETFs are distributed by Foreside Fund Services, LLC.

Copyright © 2018 Innovator Capital Management, LLC.

800.208.5212